Literature DB >> 13106886

Some chemical factors in the pathogenesis of atherosclerosis.

D P BARR.   

Abstract

Entities:  

Keywords:  ARTERIOSCLEROSIS/etiology and pathogenesis

Mesh:

Year:  1953        PMID: 13106886     DOI: 10.1161/01.cir.8.5.641

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  The regulation of the human serum-cholesterol level.

Authors:  H GORDON
Journal:  Postgrad Med J       Date:  1959-04       Impact factor: 2.401

2.  The relationship between the serum lipids and the development of ischaemic heart disease.

Authors:  B BRONTE-STEWART
Journal:  Postgrad Med J       Date:  1959-04       Impact factor: 2.401

3.  Cardiological problems in younger women; including those of pregnancy and the puerperium.

Authors:  A R GILCHRIST
Journal:  Br Med J       Date:  1963-01-26

4.  The effect of epi-oestradiol benzoate on cholesterol induced atherosclerosis in the chicken.

Authors:  R S CAMPBELL; G CHURCH; M DICK; T D LAWRIE; R PIRRIE; W C WATSON
Journal:  Br J Exp Pathol       Date:  1959-08

5.  [Serum lipoproteins in healthy and arteriosclerotic persons].

Authors:  F W FISCHER
Journal:  Klin Wochenschr       Date:  1957-04-15

6.  The relation of food and exercise to atherosclerosis and coronary thrombosis.

Authors:  H LERICHE
Journal:  Can Med Assoc J       Date:  1956-08-01       Impact factor: 8.262

7.  A study of serum lipoproteins in normal and atherosclerotic patients by paper electrophoretic techniques.

Authors:  E L DURRUM; M R HYATT; W P JENCKS; M R JETTON; T W MATTINGLY
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808

8.  LIPIDS and atheroma.

Authors: 
Journal:  Br Med J       Date:  1955-10-22

9.  The morphology of coronary atherosclerosis in man.

Authors:  T CRAWFORD
Journal:  Proc R Soc Med       Date:  1955-08

10.  The treatment of obliterative vascular disease.

Authors:  D M MORRISSEY
Journal:  Ann R Coll Surg Engl       Date:  1954-10       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.